{"id":8609,"date":"2026-01-29T04:15:27","date_gmt":"2026-01-29T04:15:27","guid":{"rendered":"https:\/\/drhasanmorcali.com\/serviks-rahim-agzi-kanseri"},"modified":"2026-06-10T07:26:03","modified_gmt":"2026-06-10T07:26:03","slug":"cervical-cancer","status":"publish","type":"page","link":"https:\/\/drhasanmorcali.com\/en\/cervical-cancer","title":{"rendered":"Cervical Cancer"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n \n
\n
\n
\n \n
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Cellular changes arising in the cervical region do not progress at the same speed or in the same way in every individual. In some cases these changes can be observed without creating symptoms for a long time, while in some people findings that can be noticed at an earlier stage may arise. For this reason, the information presented about cervical cancer<\/strong> aims to contribute to individuals gaining general awareness about reproductive system health.<\/p>

The cellular structure in the cervical tissue can show characteristics sensitive to hormonal changes and environmental effects. In particular, conditions associated with certain viruses are among the factors that can be taken into account in the monitoring and assessment processes addressed under the heading of cervical (uterine cervix) cancer<\/strong>. These assessments are addressed within the framework of individual characteristics such as personal health history and age.<\/p>

Population-based screening programmes are accepted among the preventive health practices that contribute to obtaining information about cervical cancer<\/strong> at an early stage. Regular gynaecological assessments and screening tests are among the general approaches aimed at protecting reproductive system health.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n What Is Cervical (Uterine Cervix) Cancer ?<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Cervical cancer<\/strong> refers to a tumoral disease group<\/strong> associated with the structural and genetic changes<\/strong> that can develop over time in the cells located in the cervix (uterine cervix)<\/strong> tissue forming the lower part of the uterus. The cervical tissue is one of the important anatomical regions of the reproductive system, forms the transition area between the vagina and the uterus, and has a structure that can be affected by hormonal changes.<\/p>

The changes occurring in the multiplication and renewal mechanisms<\/strong> of the cells in this region can lead to cellular accumulations that can affect tissue integrity. Cervical cancer<\/strong> is evaluated as a clinical picture associated with these cellular changes showing an increase in a certain pattern over time.<\/p>

The cellular changes that can occur in the cervical tissue can, in some individuals, progress for a long time without creating a noticeable complaint. For this reason, the regular clinical assessments and screening approaches<\/strong> carried out for cervical health are addressed within the scope of general health practices in the monitoring of the structural integrity of the cervical tissue.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n How Does Cervical Cancer Develop ?<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The cervical cancer development process<\/strong> refers to a long-term cellular change process associated with microscopic-level changes<\/strong> that accumulate over time in the genetic structure of the cells forming the cervical tissue. These changes can lead to differences in the normal multiplication and renewal cycles of the cells.<\/p>

This process can show a characteristic that can progress slowly<\/strong> in most individuals and can proceed without creating noticeable clinical complaints in the early stages. The initial stages of cellular changes in the cervical tissue can often be noticed through microscopic findings detected during routine screening and monitoring practices<\/strong>.<\/p>

Since the cervical tissue<\/strong> has a structure that can be affected by hormonal changes, the cellular change process is evaluated together with individual hormonal characteristics and the general health profile. For this reason, the development of cervical cancer is a biological process that is not reduced to a single cause and is addressed as multifactorial<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n How Common Is Cervical Cancer? In Whom Is It Seen More Frequently?\n<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Cervical cancer<\/strong> is among the cancer types reported in women worldwide, and its incidence<\/strong> can vary according to the demographic structure of countries, the prevalence of health screening programmes and record systems. The level of social awareness and the presence of regular screening practices are accepted among the elements that can have an effect on the reported rates.<\/p>

In clinical assessments, age<\/strong>, immune system characteristics<\/strong>, some environmental factors<\/strong> and the individual’s general health profile are among the variables taken into account in risk assessments related to cervical health. The presence of these factors does not mean that cervical cancer will necessarily develop in every individual; the assessment is made in line with individual medical data.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n At What Age Does Cervical Cancer Occur ?<\/span> <\/h3>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Cervical cancer<\/strong> is a disease group that can be reported in different age groups. Epidemiological data reveal that the rates of occurrence can show an increasing tendency in older age groups, while some cases are also defined at young ages<\/strong>. For this reason, age<\/strong> is not accepted as a determining criterion on its own for cervical cancer, and individual risk assessment is addressed together with numerous clinical variables.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n What Are the Symptoms of Cervical Cancer ?\n<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The symptoms of cervical cancer<\/strong> can vary between individuals depending on the location of the disease within the cervical tissue and its development process. In some people, a noticeable complaint may not be observed in the early stages, and this may lead to the cellular changes occurring in the cervical tissue being noticed over time.<\/p>

The cervical cancer symptoms<\/strong> that can be reported in later stages are mostly defined as general complaints related to the lower genital system. Among the findings that can be included in clinical assessments may be complaints such as abnormal vaginal bleeding<\/strong>, bleeding after intercourse<\/strong>, a change in the amount or smell of vaginal discharge<\/strong>, a feeling of discomfort in the groin and lower back region<\/strong> and burning or difficulty when urinating<\/strong>.<\/p>

Since these findings can also be seen in infections, hormonal changes and different gynaecological conditions, they are not accepted as diagnostic on their own<\/strong>. For this reason, such complaints associated with the cervical region are addressed within the scope of clinical assessment and, where deemed necessary, evaluated with a gynaecological examination and suitable examinations.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n What Is HPV? Its Relationship With Cervical Cancer<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

HPV (Human Papillomavirus)<\/strong> refers to a broad group of viruses that can affect skin and mucosal surfaces. There are numerous different types belonging to this virus group, and some types can be associated with changes in the cellular structure when they show a long-term presence in the cervical tissue<\/strong>.<\/p>

HPV infection<\/strong> can often proceed without leading to noticeable clinical complaints. A long-term presence of HPV in the cervical cells can, in some individuals, lead to the assessment of changes associated with a differentiation of the cellular renewal mechanisms. For this reason, HPV is addressed as one of the biological factors taken into account in the clinical monitoring processes for cervical health.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n Does HPV Always Turn Into Cancer ?<\/span> <\/h3>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

No. HPV positivity<\/strong> does not on its own indicate that cervical cancer has developed. A large portion of HPV infections can be suppressed over time by the individual’s immune system<\/strong> or can proceed without creating a clinically noticeable picture. For this reason, the presence of HPV is accepted as a biological condition that may require monitoring<\/strong> in the assessment of cellular changes in the cervical tissue; however, it is not diagnostic on its own.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n How Is Cervical Cancer Diagnosed ?<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The diagnosis of cervical cancer<\/strong> covers a multi-stage clinical assessment process<\/strong> aimed at evaluating the cellular and structural changes occurring in the cervical tissue with scientific methods. In this process, different diagnostic approaches are used together to address the general condition of the cervical tissue in detail.<\/p>

In the first stage, the individual’s medical history<\/strong> and current gynaecological complaints are evaluated. The gynaecological examination<\/strong> then carried out can provide general information regarding the clinical appearance of the cervix and surrounding tissues. Smear test results<\/strong> are among the screening data that contribute to the assessment of the structural characteristics of the cervical cells.<\/p>

The colposcopic assessment<\/strong> carried out in situations deemed necessary allows the cervical surface to be examined in detail with magnified images. The biopsy samples<\/strong> taken from suspicious areas are sent for pathological examination. This pathological assessment<\/strong> is accepted as the basic reference in classifying the cells according to their microscopic characteristics and contributes to the scientific clarification of the cervical cancer diagnosis.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n The Stages of Cervical Cancer\n<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The stages of cervical cancer<\/strong> refer to the medical classification systems<\/strong> used to describe the level of spread within the body of the cellular changes detected in the cervical tissue. In the staging process, the size of the structural change in the cervical tissue, its relationship with surrounding tissues and its distribution throughout the body are evaluated together.<\/p>

When determining the stage, clinical parameters such as the tumour size<\/strong>, contact or spread findings with neighbouring tissues, lymph node involvement<\/strong> and spread to distant organs<\/strong> are taken into account. This data is interpreted together with imaging methods and, in situations deemed necessary, pathological examination results.<\/p>

Stage information<\/strong> serves to express the current spread status of the disease in a common medical language and is among the basic data referenced in structuring clinical monitoring and assessment plans<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n What Is Metastasis? Where Can Cervical Cancer Spread?\n<\/span> <\/h3>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Metastasis<\/strong> is a medical term describing the carrying of tumour cells from the region they are in to different areas of the body. In some advanced stages of cervical cancer, findings of spread of the cellular changes towards surrounding tissues<\/strong> and, in certain situations, towards distant organs<\/strong> can be addressed in clinical assessments. Such spread possibilities are evaluated together with imaging methods and pathological examination results, contributing to the structuring of the clinical monitoring process.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n Cervical Cancer Treatment Methods\n<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Cervical cancer treatment methods<\/strong> refer to the medical assessment plans<\/strong> structured by addressing together the level of spread of the cellular changes detected in the cervical tissue, the pathological assessment findings and the individual’s general health profile. These approaches aim for the current clinical picture of the disease to be addressed in line with scientific criteria.<\/p>

The surgical interventions<\/strong> included in clinical practice cover the medical procedures planned for removing the structural changes in the cervical region. These interventions are evaluated by taking into account the anatomical characteristics of the cervix and its relationship with surrounding tissues.<\/p>

Drug-based applications<\/strong> are clinical approaches that include various medical drugs used with the aim of systemic effects. Radiation-based methods<\/strong>, in turn, refer to the medical applications in which radiation energy directed to certain areas is used in a controlled manner.<\/p>

Which approach or approaches are evaluated is determined by addressing together the individual’s clinical data<\/strong>, imaging results and pathological examination findings. For this reason, treatment planning is structured not with generalising templates, but in line with individual medical assessment data.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n Post-Treatment Follow-Up and General Life in Cervical Cancer\n<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The clinical follow-up process carried out after cervical cancer treatment<\/strong> is a health approach aimed at the regular assessment of the individual’s general health condition and the monitoring of changes that may develop in relation to treatment. This process is important in terms of monitoring the structural integrity of the cervical tissue, its relationship with surrounding tissues and general wellbeing.<\/p>

Post-treatment check-ups are carried out at intervals planned by the physician, and in each assessment period various medical tools such as a clinical examination<\/strong>, imaging methods<\/strong> or laboratory tests<\/strong> can be used. The aim is to ensure that the individual’s current condition is monitored in line with scientific criteria.<\/p>

The arrangement of daily life habits is addressed as an important topic after the treatment process. Nutrition<\/strong>, physical activity<\/strong> and general health behaviours<\/strong> are shaped in line with the individual’s needs and the physician’s opinion. These recommendations are evaluated within the framework of approaches that take into account personal differences and the individual’s general health profile.<\/p>

In the post-treatment period, the individual’s physical and emotional adaptation process is also taken into account. For this reason, the follow-up process does not consist only of monitoring clinical findings, but refers to a holistic health approach that supports the individual’s general wellbeing.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n Early Diagnosis and Screening in Cervical Cancer\n<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Early diagnosis in cervical cancer<\/strong> refers to the clinical assessment processes<\/strong> aimed at noticing the cellular and structural changes that may occur in the cervical tissue before noticeable clinical complaints arise. This approach aims to contribute to raising awareness about cervical health and to the timely monitoring of possible changes.<\/p>

Screening programmes<\/strong> cover the clinical monitoring practices planned in line with a physician’s recommendation<\/strong> by taking into account variables such as the individual’s age, gynaecological history, immune system characteristics and general health profile. In these processes, methods such as the smear test, HPV assessments and gynaecological examination are addressed together to evaluate the structural characteristics of the cervical cells.<\/p>

At what intervals the screening and early diagnosis approaches are applied is determined in line with the personal risk profile and the clinical findings. For this reason, the early diagnosis and screening processes<\/strong> are structured as part of individual medical assessment plans.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\r\n
\r\n
\r\n

\r\n Information About Clinical Monitoring and Assessment Processes\n<\/span> <\/h2>\r\n <\/div>\r\n <\/div>\r\n<\/div>\r\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Oncology Specialist Dr. Hasan Morcal\u0131<\/strong> provides medical consultation and clinical assessment services<\/strong> regarding the diagnosis, monitoring and assessment processes of various oncological diseases<\/strong>, including cervical (uterine cervix) cancer<\/strong>, in his clinical practice. These services cover the addressing of the individual’s current clinical findings<\/strong>, the planning of the laboratory and imaging examinations<\/strong> deemed necessary and the structuring of the monitoring process in line with scientific criteria.<\/p>

In the clinical assessment processes, the pathological examination results, imaging findings and clinical examination data are addressed together to create a holistic medical framework. This approach refers to a clinical assessment process that contributes to the individual’s current health condition being monitored in line with scientific medical practice<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Kanserler ve Tedavileri<\/span><\/h2>